查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1837165

泌尿系統設備市場：按產品類型、技術、應用和最終用戶 - 全球預測 2025-2032

Urology Devices Market by Product Type, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年泌尿系統設備市場規模將成長至 918.8 億美元，複合年成長率為 9.51%。

主要市場統計數據
基準年2024年 444.1億美元
預計2025年 485.6億美元
預測年份：2032年 918.8億美元
複合年成長率（%） 9.51%

簡要回顧泌尿系統醫療設備領域不斷發展變化的趨勢，包括人口結構變化、臨床創新、監管環境變化以及基於價值的照護動態

當前泌尿系統醫療設備市場格局呈現多種因素交織，凸顯了製定清晰策略的迫切性。人口結構朝著老化方向發展，臨床指南對微創手術的支持不斷升級，患者對更快康復和更高生活品質的期望也不斷提升，這些因素共同改變了器械設計的重點。同時，臨床醫生和醫療保健提供者要求更強力的臨床證據、更精簡的工作流程以及能夠無縫整合到現有護理路徑中的器械。

監管機構正在加強對安全性和上市後監管的審查，報銷框架也更重視價值和療效，而非手術量。這些因素，加上影像技術、能量碎石術和生物材料領域的快速成熟，正在加速產品的迭代週期。因此，從製造商到醫療保健提供相關人員必須在上市速度和可靠的臨床檢驗之間取得平衡，以維護信任並確保產品被廣泛採用。

最終，在這種環境下取得成功取決於將研發投資與務實的商業策略相結合，建立付款方和提供者的關係，以及設計出能夠帶來可衡量臨床和經濟效益的設備。透過專注互通性、臨床人體工學和以患者為中心的治療結果，公司可以調整其產品組合，以滿足緊迫的臨床需求，同時保持對新醫療模式的適應性。

從微創系統到數位診斷和整合手術平台，技術和臨床變革時期正在重塑泌尿系統治療途徑

近年來，泌尿系統護理的交付方法和設備概念發生了革命性的變化。微型化和影像技術的進步使得微創診斷和治療成為可能，降低了病患發病率，並促進了門診手術的進行。同時，能量輸送系統、雷射技術和主導結石管理工具正在拓展治療方案，使臨床醫生能夠提供更具針對性的干涉措施。

隨著整合軟體、程序分析和遠端監控增強術後護理並支持長期療效評估，數位健康和​​數據主導方法也日益受到青睞。此外，在感染控制、滅菌物流和工作流程效率至關重要的手術環境中，人們明顯傾向於使用一次性拋棄式。這一趨勢與人們對可重複使用替代品的重新關注並存，這些替代品可以透過改進滅菌技術，以負責任的方式管理生命週期成本和環境因素。

同時，監管途徑也在不斷演變，以適應組合產品和器械-藥物整合，例如塗藥支架和抗菌塗層導管。因此，商業化策略越來越需要跨職能能力，包括臨床研究、監管事務、供應鏈韌性和付款人參與。積極適應這一轉變的相關人員將更有能力將技術前景轉化為持續的臨床應用。

評估 2025 年美國新關稅對泌尿系統醫療設備供應鏈、籌資策略、成本和臨床採購慣例的累積影響

2025年美國加徵關稅對全球供應鏈產生了連鎖反應，直接影響了泌尿系統設備的採購決策、成本結構和採購慣例。嚴重依賴跨境零件採購的製造商面臨投入成本上升和利潤率壓縮的雙重壓力，迫使許多製造商尋求多元化供應商、進行近岸外包，並重新評估庫存策略。因此，醫院、急診醫院和專科診所的採購團隊在評估供應商合約時面臨越來越大的談判壓力，並重新關注整體擁有成本。

此外，關稅促使產品系列重新調整。大批量耗材和低淨利率器械面臨越來越大的壓力，需要在不影響臨床性能的情況下實現本地化生產或重新設計以實現成本效益。為此，一些製造商優先考慮模組化平台和標準化組件，以緩解關稅相關的價格波動，並加快與區域合約製造商的合作，以保持供應的連續性。這些轉變也影響了一次性和可重複使用器械之間的策略平衡，因為決策者需要權衡初始資本成本、滅菌物流和持續耗材成本。

因此，臨床醫生和採購主管正在調整設備採用時間表和選擇標準，強調可證明的效率和培訓資源，以減少手術時間和資源利用率。展望未來，組織的韌性將取決於透明的供應商生態系統、靈活的契約，以及將成本壓力轉化為醫療服務提供者和患者差異化價值提案的能力。

對產品類型、技術、臨床應用和最終用戶的深入細分洞察，為有針對性的投資和商業化策略提供訊息

細緻的細分視角有助於明確投資和臨床開發的重點。內視鏡設備包括膀胱鏡、腎臟鏡和輸尿管鏡，它們的可視化能力和操作設定各不相同。結石處理設備包括雷射系統、碎石機和取石工具，它們的資本強度和操作人員訓練要求各不相同。輸尿管支架分為藥物釋放型支架、金屬支架和聚合物支架，其通暢性和生物相容性各不相同。尿道導管包括外部導管、 Foley導管導尿管和間歇導尿管，每種導管都有其獨特的感染控制和患者友善考慮因素。肌電圖系統和壓力流分析儀等尿動力學設備有助於提高診斷準確性並最佳化護理路徑。

另外，拋棄式和可重複使用器械之間的技術分類對製造、滅菌物流和環境考量具有戰略意義。拋棄式方案有助於在易受感染的環境中推廣，並降低滅菌成本；而可重複使用系統，如果採用可靠的滅菌方案，則可以透過長期降低每次手術的耗材成本，從而證明更高的資本投資是合理的。

基於應用的細分突出了臨床重點領域，例如良性前列腺增生、膀胱癌、腎結石、尿失禁和尿道感染，每個領域都有其獨特的手術組合、後續治療方案和設備設計限制。門診手術中心、醫院和泌尿系統診所的終端使用者細分則突顯了採購週期、資金可用性、手術量和培訓資源的差異。這些細分指南產品開發優先順序的確定、臨床證據的產生以及與實際實踐環境相符的上市舉措。

美洲、歐洲、中東和非洲以及亞太地區的區域動態和採用模式將重新定義製造、監管和市場進入

區域動態對創新採用、監管預期和商業策略有著巨大的影響。在美洲，醫療保健系統融合了集中採購和分散的醫療機構決策，強調清晰的臨床經濟證據、與醫院系統的互通性以及強大的上市後支持。北美醫療保健提供者通常優先考慮程序效率和結果相關性，這推動了人們對減少住院時間和支持門診醫療擴展的技術的興趣。

歐洲、中東和非洲地區多樣化的監管環境和報銷模式既帶來了複雜性，也帶來了機會。該地區的一些國家青睞強力的臨床證據和已證實的成本效益，而另一些國家則透過專家卓越中心提供快速實施途徑。本地製造能力和區域貿易框架也會影響採購決策，因此與區域經銷商和契約製造製造商合作是任何打入市場策略的重要組成部分。

在亞太地區，由於醫療基礎設施的快速現代化和資金匱乏的市場，其應用模式各有不同。高手術量和對微創治療方案日益成長的需求，使得該地區對擴充性的設備平台和成本最佳化的耗材具有吸引力。在所有地區，關注培訓、本地臨床領導人物和供應鏈的可靠性對於實現持續應用和患者可近性至關重要。

領先泌尿系統設備公司的策略性企業行動和競爭定位，重點在於創新、夥伴關係、製造和臨床證據策略

泌尿系統設備領域的主要企業正在採用多層面的策略來保持成長和臨床相關性。許多公司優先考慮投資組合多元化，在高利潤的資本設備與耗材的經常性收益之間取得平衡，從而穩定週期性需求。投資模式不僅注重核心設備效能，還注重相關功能，例如影像引導導航、數據分析和軟體支援的工作流程，以提高臨床醫生的工作效率和病患治療效果。

策略夥伴關係、授權協議和定向收購是加速取得專業技術、擴大臨床覆蓋範圍和進入新地域市場的常用方法。同時，建立強大的臨床證據計畫和贊助研究者主導的研究對於與泌尿系統意見領袖和付款人建立信任仍然至關重要。製造彈性在企業計畫中發揮關鍵作用，投資雙重採購、品質系統和區域生產可以降低關稅和庫存風險。

在商業性，各公司正在透過專門的培訓計劃、流程支援和配套服務來最佳化其最終用戶參與模式。這些措施有助於降低採用門檻，並實現更深層的臨床整合。將卓越營運與專注的研發以及以臨床醫生為中心的競爭格局相結合的公司，將在快速發展的市場環境中保持長期競爭力。

為產業領導者提供實用且有影響力的建議，幫助他們應對供應中斷、監管複雜性，並加速泌尿系統新技術的採用

產業領導者應採取一系列切實行動，將洞見轉化為可衡量的成果。首先，尋求區域製造夥伴關係，以實現供應商多元化，增強對貿易中斷的抵禦能力，並縮短前置作業時間。此外，還應確保合約彈性，允許定價和交付條款反映不斷變化的關稅和物流環境。其次，優先投資於在門診環境中具有成熟臨床和經濟價值的技術，例如精簡的內視鏡平台和可減輕滅菌負擔和感染風險的一次性設備。

第三，它透過設計比較研究來衡量以患者為中心的治療結果和總護理成本，從而增強臨床證據的生成，從而提高付款方的參與度並促進基於價值的合約。第四，它利用數位醫療整合為醫療服務提供者提供程序分析和遠端監控功能，以增強術後管理並支持患者的長期療效。門診手術中心致力於提高吞吐量，醫院致力於提高整合系統和生命週期成本，專科診所致力於提高設備的人體工學和易用性。

最後，透過全面的培訓、模擬和程序支援專案投資於員工隊伍的提升，可以減少部署過程中的摩擦。透過結合供應鏈的審慎性、循證驅動的研發以及臨床導向的商業化，組織可以加速部署，同時最大限度地降低營運風險。

透明的調查方法，概述了用於獲得泌尿系統可靠見解的主要訪談、二手資料、專家檢驗和三角測量技術

這些見解背後的調查方法以混合方法為中心，並專注於嚴謹性、透明度和三角測量。主要研究包括對臨床醫生、採購主管、監管專家和行業高管的結構化訪談，以了解該領域對臨床需求、採購行為和應用障礙的觀點。除了定性資訊外，我們還對同行評審的臨床文獻、監管指南文件和最佳實踐進行了系統性回顧，以確保研究符合當代醫療標準。

為了檢驗和完善我們的研究結果，我們召集了一個專家小組，對假設進行質疑，並提供特定領域的細微差別。我們透過多個可用的獨立資訊來源對定量資料點進行最後覆核，並運用敏感度分析來識別穩健趨勢和瞬時市場噪音。我們根據臨床工作流程、設備功能和最終用戶特徵建立了一個細分框架，以產生與實際決策相符的可行洞察。

品管包括迭代同儕審查、來源可追溯性和方法透明度，使相關人員能夠評估結論的可靠性和適用性。在存在不確定性的情況下，明確強調考慮各種意外情況和情景，以支援策略規劃和風險規避。

綜合結論強調了泌尿系統醫療設備生態系統相關人員的策略機會、風險緩解和關鍵曲折點

總而言之，泌尿系統醫療設備的格局由多種因素共同決定：臨床對微創、高效治療的需求，推動精準醫療和數據整合的技術進步，以及來自供應鏈動態變化和報銷模式演變的商業性壓力。這些動態既帶來了挑戰，也帶來了機會。在價值驅動型日益增強的環境中，那些投資於具有臨床意義的創新、韌性供應鏈和實證商業化的公司將脫穎而出。

專注於產品類型、技術形式、臨床應用和最終用戶環境的細分，有助於更好地分配研發和上市資源。區域策略必須根據當地監管要求、採購行為和醫療保健基礎設施量身定做，以確保成功進入市場並持續應用。最終，那些兼具營運紀律、臨床夥伴關係和策略敏捷性的組織將最有能力將創新轉化為改善的患者治療效果和持續的商業性成功。

相關人員應將當前時期視為完善管道、增強供應彈性和深化臨床參與的機會，以便下一代泌尿系統醫療設備的承諾能夠在日常實踐中實現。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 人工智慧驅動的成像演算法改善早期膀胱癌檢測
  • 遠端患者監護平台，最佳化慢性閉尿症管理
  • 可生物分解輸尿管支架技術降低二次介入率
  • 使用機器人輔助系統進行單孔微創切除術
  • 感測器整合導管解決方案，用於對抗導管相關的尿道感染
  • 3D列印患者專用腎臟植入改善泌尿系統重組結果
  • 人工智慧預測分析可預測腎結石患者復發的風險

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章泌尿系統設備市場（依產品類型）

  • 排泄管理
    • 介入設備
    • 非侵入式設備
    • 陰莖人工替代物
  • 內視鏡設備
    • 膀胱鏡
    • 腎鏡
    • 輸尿管鏡
  • 結石管理設備
    • 雷射系統
    • 石料破碎裝置
    • 除石工具
  • 輸尿管支架
    • 藥物釋放型支架
    • 金屬支架
    • 聚合物支架
  • 導尿管
    • 外導管
    • Foley導管
    • 間歇導尿管
  • 動態裝置
    • 肌電圖系統
    • 壓力和流量分析儀

第9章泌尿系統設備市場（按技術）

  • 一次性的
  • 可重複使用的

第 10 章泌尿系統設備市場（依應用）

  • 良性攝護腺增生
  • 膀胱癌
  • 腎結石
  • 尿失禁
  • 尿道感染

第 11 章泌尿系統設備市場（依最終用戶）

  • 門診手術中心
  • 醫院
  • 泌尿系統診所

第12章泌尿系統設備市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章泌尿系統設備市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章泌尿系統設備市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Boston Scientific Corporation
    • Johnson & Johnson
    • Olympus Corporation
    • Medtronic plc
    • Stryker Corporation
    • Teleflex Incorporated
    • Coloplast A/S
    • Cook Medical LLC
    • KARL STORZ SE & Co. KG
    • Richard Wolf GmbH
Product Code: MRR-034B50030338

The Urology Devices Market is projected to grow by USD 91.88 billion at a CAGR of 9.51% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 44.41 billion
Estimated Year [2025] USD 48.56 billion
Forecast Year [2032] USD 91.88 billion
CAGR (%) 9.51%

A concise introduction to the evolving urology devices landscape driven by demographics, clinical innovation, regulatory changes and value-based care dynamics

The contemporary landscape for urology devices is characterized by intersecting drivers that amplify the urgency for strategic clarity. Demographic shifts toward older populations, evolving clinical guidelines that favor minimally invasive procedures, and growing patient expectations for faster recovery and improved quality of life are collectively reshaping device design priorities. Concurrently, clinicians and healthcare providers are demanding stronger clinical evidence, streamlined workflows, and devices that integrate seamlessly into existing care pathways.

Regulatory agencies have intensified scrutiny on safety and post-market surveillance, while reimbursement frameworks increasingly prioritize value and outcomes over procedural volume. These forces, together with rapid technology maturation in imaging, energy-based lithotripsy, and biomaterials, are accelerating product iteration cycles. As a result, stakeholders from manufacturers to providers must balance speed to market with robust clinical validation to maintain trust and ensure adoption.

Ultimately, success in this environment depends on aligning R&D investments with pragmatic commercial strategies, cultivating payer and provider relationships, and designing devices that deliver measurable clinical and economic benefits. By focusing on interoperability, clinician ergonomics, and patient-centered outcomes, organizations can position their portfolios to address immediate clinical needs while remaining adaptable to emerging care models.

Transformative technological and clinical shifts reshaping urology care pathways from minimally invasive systems to digital diagnostics and integrated surgical platforms

Recent years have witnessed transformative shifts that are redefining how urology care is delivered and how devices are conceived. Advances in miniaturization and imaging are enabling less invasive diagnostics and therapies, reducing patient morbidity and facilitating procedures in ambulatory settings. At the same time, energy delivery systems, laser technologies, and precision-driven stone management tools are expanding therapeutic options and enabling clinicians to tailor interventions with greater specificity.

Digital health and data-driven approaches are also gaining traction, as integrated software, procedural analytics, and remote monitoring enhance postoperative care and support longitudinal outcome measurement. Furthermore, there is a clear movement toward single-use disposables in procedural environments where infection control, sterilization logistics, and workflow efficiency are paramount. This trend coexists with renewed interest in reusables where lifecycle cost and environmental considerations can be responsibly managed through improved sterilization technologies.

In parallel, regulatory pathways are evolving to better accommodate combination products and device-drug integrations, such as drug-eluting stents and antimicrobial-coated catheters. As a result, commercialization strategies increasingly rely on cross-functional capabilities that span clinical research, regulatory affairs, supply chain resilience, and payer engagement. Stakeholders that proactively adapt to these shifts will be better placed to convert technological promise into durable clinical adoption.

Assessing the cumulative effects of new United States tariffs in 2025 on urology device supply chains, sourcing strategies, costs and clinical procurement practices

The imposition of United States tariffs in 2025 created a ripple effect across global supply chains that directly affected sourcing decisions, cost structures, and procurement practices for urology devices. Manufacturers that relied heavily on cross-border component sourcing confronted elevated input costs and compressed margins, prompting many to reassess supplier diversification, nearshoring, and inventory strategies. As a consequence, procurement teams in hospitals, ambulatories, and specialty clinics faced tighter negotiations and a renewed emphasis on total cost of ownership when evaluating vendor contracts.

Moreover, the tariffs fostered a recalibration of product portfolios. High-volume consumables and devices with thin margins saw intensified pressure to localize manufacturing or to redesign for cost-effective production without compromising clinical performance. In response, several manufacturers prioritized modular platforms and standardized components to mitigate tariff-related price volatility, while others accelerated partnerships with regional contract manufacturers to preserve supply continuity. These shifts also influenced the strategic balance between disposable and reusable device offerings, with decision makers weighing the trade-offs between upfront capital costs, sterilization logistics, and ongoing consumable spend.

Clinicians and procurement leaders consequently adapted adoption timelines and device selection criteria, placing greater weight on demonstrable efficiencies and training resources that reduce procedural time and resource utilization. Looking forward, organizational resilience will depend on transparent supplier ecosystems, contractual flexibility, and the ability to translate cost pressures into differentiated value propositions for providers and patients.

Deep segmentation insights across product types, technologies, clinical applications and end users to inform targeted investment and commercialization strategies

A nuanced view of segmentation clarifies where investment and clinical development should be concentrated. Within product typology, continence management spans interventional devices, noninterventional devices, and penile prostheses, each responding to distinct clinical needs and reimbursement pathways; endoscopy devices include cystoscopes, nephroscopes, and ureteroscopes that differ by visualization capabilities and procedural settings; stone management devices encompass laser systems, lithotripsy devices, and stone removal tools that vary in capital intensity and operator training requirements; ureteral stents are differentiated across drug-eluting stents, metal stents, and polymer stents with divergent profiles for patency and biocompatibility; urinary catheters range from external catheters and Foley catheters to intermittent catheters each with unique infection control and patient usability considerations; and urodynamic devices such as EMG systems and pressure flow analyzers support diagnostic precision and care pathway optimization.

Separately, technology segmentation between disposable and reusable devices has strategic implications for manufacturing, sterilization logistics, and environmental considerations. Disposable solutions can accelerate adoption in infection-sensitive environments and reduce sterilization overhead, while reusable systems justify higher capital investment through lower per-procedure consumable costs over time when supported by robust sterilization protocols.

Application-based segmentation highlights clinical focus areas including benign prostatic hyperplasia, bladder cancer, kidney stones, urinary incontinence, and urinary tract infections, each presenting unique procedural mixes, follow-up regimens, and device design constraints. End-user segmentation across ambulatory surgical centers, hospitals, and urology clinics underscores variation in purchase cycles, capital availability, procedural throughput, and training resources. Together, these segmentation lenses guide prioritization of product development, clinical evidence generation, and go-to-market initiatives that align with real-world practice settings.

Regional dynamics and adoption patterns across the Americas, Europe Middle East & Africa and Asia-Pacific that are redefining manufacturing, regulation and market access

Regional dynamics exert a powerful influence on innovation adoption, regulatory expectations, and commercial strategy. In the Americas, healthcare systems display a mix of centralized procurement and fragmented provider decision making, which places a premium on clear clinical-economic evidence, interoperability with hospital systems, and robust post-market support. North American providers often prioritize procedural efficiency and outcomes linkage, driving interest in technologies that reduce length of stay and support ambulatory care expansion.

In Europe, Middle East & Africa, diverse regulatory landscapes and reimbursement models create both complexity and opportunity. Several countries in this region favor strong clinical evidence and cost-effectiveness demonstrations, while others offer pathways for rapid adoption through specialist centers of excellence. Local manufacturing capabilities and regional trade frameworks also influence sourcing decisions, making partnerships with regional distributors and contract manufacturers an essential part of market entry strategies.

Asia-Pacific presents heterogeneous adoption patterns driven by rapidly modernizing healthcare infrastructure in some markets and constrained capital in others. High procedure volumes and growing demand for minimally invasive options make the region attractive for scalable device platforms and cost-optimized consumables. Across all regions, attention to training, local clinical champions, and supply chain reliability remains essential to achieving durable adoption and patient access.

Strategic corporate behaviors and competitive positioning of leading urology device companies highlighting innovation, partnerships, manufacturing and clinical evidence strategies

Leading companies in the urology device space are adopting multifaceted strategies to sustain growth and clinical relevance. Many prioritize portfolio diversification that balances high-margin capital equipment with consumable recurring revenue, enabling stability through cyclical demand. Investment patterns emphasize not only core device performance but also adjacent capabilities such as image-guided navigation, data analytics, and software-enabled workflows that enhance clinician productivity and procedural outcomes.

Strategic partnerships, licensing agreements, and targeted acquisitions are common approaches to accelerate access to specialized technologies, broaden clinical reach, and enter new geographic markets. At the same time, establishing robust clinical evidence programs and sponsoring investigator-initiated studies remain central to building credibility with urology thought leaders and payers. Manufacturing resilience features prominently in corporate planning, with investments in dual sourcing, quality systems, and regional production to reduce tariff exposure and inventory risk.

Commercially, companies are optimizing their engagement models with end users by creating dedicated training programs, procedural support, and bundled service offerings. These moves help lower adoption barriers and create deeper clinical integration. Organizations that combine operational excellence with focused R&D and clinician-centric commercial strategies are best positioned to sustain long-term competitiveness in a rapidly evolving landscape.

Practical, high-impact recommendations for industry leaders to navigate supply disruptions, regulatory complexity and accelerate adoption of novel urology technologies

Industry leaders should adopt a set of pragmatic actions to translate insight into measurable outcomes. First, diversify supply sources and pursue regional manufacturing partnerships to enhance resilience against trade disruptions and to shorten lead times. This should be accompanied by contractual flexibility that allows pricing and delivery terms to reflect evolving tariff and logistics environments. Second, prioritize investments in technologies that demonstrate clear clinical and economic value in ambulatory settings, such as streamlined endoscopy platforms and single-use devices that reduce sterilization burden and infection risk.

Third, strengthen clinical evidence generation by designing comparative studies that measure patient-centered outcomes and total cost of care, thereby improving payer engagement and facilitating value-based contracting. Fourth, leverage digital health integration to offer providers procedural analytics and remote monitoring capabilities that enhance postoperative management and support long-term patient outcomes. Fifth, refine commercialization approaches by tailoring messaging and pricing to specific end users: ambulatory surgical centers will respond to throughput improvements, hospitals to integrated systems and lifecycle costs, and specialized clinics to device ergonomics and ease of use.

Finally, invest in workforce enablement through comprehensive training, simulation, and procedural support programs to reduce adoption friction. By combining supply chain prudence, evidence-focused R&D, and clinically aligned commercialization, organizations can accelerate adoption while minimizing operational risk.

Transparent research methodology outlining primary interviews, secondary sources, expert validation and triangulation techniques used to produce robust urology insights

The research approach underpinning these insights is anchored in a blended methodology that emphasizes rigor, transparency, and triangulation. Primary research included structured interviews with clinicians, procurement leaders, regulatory specialists, and industry executives to capture frontline perspectives on clinical needs, purchasing behavior, and adoption barriers. These qualitative inputs were complemented by a systematic review of peer-reviewed clinical literature, regulatory guidance documents, and procedural best practices to ensure alignment with contemporary standards of care.

To validate and refine findings, expert panels were convened to challenge assumptions and provide domain-specific nuance. Quantitative data points were cross-checked through multiple independent sources where available, and sensitivity analyses were applied to identify robust trends versus transient market noise. Segmentation frameworks were derived from clinical workflows, device functionality, and end-user characteristics to produce actionable insights that align with real-world decision making.

Quality control measures included iterative peer review, source traceability, and methodological transparency so stakeholders can assess the confidence and applicability of conclusions. Where uncertainty exists, the research explicitly highlights contingent factors and scenario considerations to support strategic planning and risk mitigation.

Concluding synthesis that highlights strategic opportunities, risk mitigations and the critical inflection points for stakeholders across the urology device ecosystem

In conclusion, the urology devices landscape is defined by converging forces: clinical demand for less invasive and more effective therapies, technological advances that enable precision care and data integration, and commercial pressures driven by supply chain dynamics and evolving reimbursement models. These dynamics create both challenges and opportunities. Organizations that invest in clinically meaningful innovation, resilient supply chains, and evidence-based commercialization will differentiate themselves in an increasingly value-focused environment.

Attention to segmentation-across product types, technology formats, clinical applications, and end-user settings-enables more precise allocation of R&D and go-to-market resources. Regional strategies must be tailored to local regulatory expectations, procurement behaviors, and healthcare infrastructure to ensure successful entry and sustained adoption. Ultimately, the organizations that combine operational discipline, clinical partnership, and strategic agility will be best positioned to convert innovation into improved patient outcomes and durable commercial success.

Stakeholders should view the current period as an opportunity to refine pipelines, fortify supply resilience, and deepen clinical engagement, so that the promise of next-generation urology devices is realized in everyday care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. AI-driven imaging algorithms improving early bladder cancer detection
  • 5.2. Remote patient monitoring platforms optimizing chronic urinary retention management
  • 5.3. Biodegradable ureteral stent technology reducing secondary intervention rates
  • 5.4. Robotic-assisted systems enabling single-port minimally invasive prostatectomy procedures
  • 5.5. Sensor-integrated catheter solutions tackling catheter-associated urinary tract infections
  • 5.6. 3D-printed patient-specific renal implants improving outcomes in reconstructive urology
  • 5.7. AI-powered predictive analytics forecasting stone recurrence risk in nephrolithiasis patients

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Urology Devices Market, by Product Type

  • 8.1. Continence Management
    • 8.1.1. Interventional Devices
    • 8.1.2. Noninterventional Devices
    • 8.1.3. Penile Prosthesis
  • 8.2. Endoscopy Devices
    • 8.2.1. Cystoscopes
    • 8.2.2. Nephroscopes
    • 8.2.3. Ureteroscopes
  • 8.3. Stone Management Devices
    • 8.3.1. Laser Systems
    • 8.3.2. Lithotripsy Devices
    • 8.3.3. Stone Removal Tools
  • 8.4. Ureteral Stents
    • 8.4.1. Drug Eluting Stents
    • 8.4.2. Metal Stents
    • 8.4.3. Polymer Stents
  • 8.5. Urinary Catheters
    • 8.5.1. External Catheters
    • 8.5.2. Foley Catheters
    • 8.5.3. Intermittent Catheters
  • 8.6. Urodynamic Devices
    • 8.6.1. EMG Systems
    • 8.6.2. Pressure Flow Analyzers

9. Urology Devices Market, by Technology

  • 9.1. Disposable
  • 9.2. Reusable

10. Urology Devices Market, by Application

  • 10.1. Benign Prostatic Hyperplasia
  • 10.2. Bladder Cancer
  • 10.3. Kidney Stones
  • 10.4. Urinary Incontinence
  • 10.5. Urinary Tract Infection

11. Urology Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Urology Clinics

12. Urology Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Urology Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Urology Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Boston Scientific Corporation
    • 15.3.2. Johnson & Johnson
    • 15.3.3. Olympus Corporation
    • 15.3.4. Medtronic plc
    • 15.3.5. Stryker Corporation
    • 15.3.6. Teleflex Incorporated
    • 15.3.7. Coloplast A/S
    • 15.3.8. Cook Medical LLC
    • 15.3.9. KARL STORZ SE & Co. KG
    • 15.3.10. Richard Wolf GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UROLOGY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL UROLOGY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL UROLOGY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. UROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. UROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL UROLOGY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL UROLOGY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2024 (USD MILLION)

TABLE 3